C J Bowmer

1.3k total citations
68 papers, 1.1k citations indexed

About

C J Bowmer is a scholar working on Molecular Biology, Nephrology and Oncology. According to data from OpenAlex, C J Bowmer has authored 68 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 18 papers in Nephrology and 15 papers in Oncology. Recurrent topics in C J Bowmer's work include Drug Transport and Resistance Mechanisms (13 papers), Pharmacological Effects and Toxicity Studies (13 papers) and Adenosine and Purinergic Signaling (12 papers). C J Bowmer is often cited by papers focused on Drug Transport and Resistance Mechanisms (13 papers), Pharmacological Effects and Toxicity Studies (13 papers) and Adenosine and Purinergic Signaling (12 papers). C J Bowmer collaborates with scholars based in United Kingdom and Israel. C J Bowmer's co-authors include M S Yates, W E Lindup, Michael S. Yates, M G Collis, Richard J. Knight, Mohammad Reza Panjehshahin, R. Hartley, Asipu Sivaprasadarao, Jane Smith and J T Brocklebank and has published in prestigious journals such as British Journal of Cancer, Journal of Pharmacology and Experimental Therapeutics and Trends in Pharmacological Sciences.

In The Last Decade

C J Bowmer

67 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C J Bowmer United Kingdom 19 339 242 227 195 177 68 1.1k
P. D. Niedmann Germany 19 427 1.3× 164 0.7× 147 0.6× 376 1.9× 81 0.5× 40 1.8k
M I Sheikh Denmark 20 587 1.7× 25 0.1× 89 0.4× 232 1.2× 381 2.2× 65 1.3k
J. D. Tange Australia 24 376 1.1× 28 0.1× 460 2.0× 105 0.5× 192 1.1× 77 1.9k
Ian Kippen United States 19 587 1.7× 30 0.1× 316 1.4× 128 0.7× 239 1.4× 32 1.1k
Francesca Franco Italy 21 571 1.7× 80 0.3× 56 0.2× 53 0.3× 489 2.8× 57 1.8k
Kwan Leung United States 23 688 2.0× 207 0.9× 18 0.1× 53 0.3× 234 1.3× 56 1.8k
David Hicks United States 19 229 0.7× 34 0.1× 24 0.1× 103 0.5× 88 0.5× 50 1.1k
M. Galli-Kienle Italy 19 441 1.3× 62 0.3× 18 0.1× 113 0.6× 186 1.1× 30 1.4k
A. Farah United States 20 565 1.7× 26 0.1× 67 0.3× 90 0.5× 93 0.5× 85 1.5k
Géraldine M. Ferron United States 19 303 0.9× 32 0.1× 59 0.3× 210 1.1× 231 1.3× 28 1.1k

Countries citing papers authored by C J Bowmer

Since Specialization
Citations

This map shows the geographic impact of C J Bowmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C J Bowmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C J Bowmer more than expected).

Fields of papers citing papers by C J Bowmer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C J Bowmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C J Bowmer. The network helps show where C J Bowmer may publish in the future.

Co-authorship network of co-authors of C J Bowmer

This figure shows the co-authorship network connecting the top 25 collaborators of C J Bowmer. A scholar is included among the top collaborators of C J Bowmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C J Bowmer. C J Bowmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, Jane, et al.. (2001). Immunolocalisation of adenosine A1 receptors in the rat kidney. Biochemical Pharmacology. 61(2). 237–244. 43 indexed citations
2.
Smith, Jane, et al.. (2000). Differential expression of renal adenosine A1 receptors induced by acute renal failure. Biochemical Pharmacology. 59(6). 727–732. 13 indexed citations
3.
Banks, Rosamonde E., M A Forbes, Poulam M. Patel, et al.. (2000). SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT GLYCOSYLATED INTERLEUKIN 6 IN PATIENTS WITH CANCER: PHARMACOKINETICS, PHARMACODYNAMICS AND IMMUNOMODULATORY EFFECTS. Cytokine. 12(4). 388–396. 14 indexed citations
4.
Smith, Jane, et al.. (1999). Regulation of renal adenosine A1 receptors: effect of dietary sodium chloride. European Journal of Pharmacology. 384(1). 71–79. 14 indexed citations
5.
Rajaian, Hamid, H.W. Symonds, & C J Bowmer. (1997). Drug binding sites on chicken albumin: a comparison to human albumin. Journal of Veterinary Pharmacology and Therapeutics. 20(6). 421–426. 8 indexed citations
6.
Morton, Michael J., et al.. (1997). Renal adenosine A1 receptor binding characteristics and mRNA levels during the development of acute renal failure in the rat. British Journal of Pharmacology. 120(5). 947–953. 19 indexed citations
7.
Banks, Rosamonde E., M A Forbes, Meenu Wadhwa, et al.. (1997). Treatment of metastatic renal cell carcinoma with subcutaneous interleukin 2: evidence for non-renal clearance of cytokines. British Journal of Cancer. 75(12). 1842–1848. 4 indexed citations
8.
Bowmer, C J, et al.. (1995). Renal Haemodynamic Responses to Adenosine in Acute Renal Failure. ˜The œNephron journals/Nephron journals. 71(2). 184–189. 7 indexed citations
9.
Knight, Richard J., C J Bowmer, & M S Yates. (1993). The diuretic action of 8‐cyclopentyl‐1,3‐dipropylxanthine, a selective A1 adenosine receptor antagonist. British Journal of Pharmacology. 109(1). 271–277. 61 indexed citations
10.
Wang, Yi, et al.. (1993). Absorption of N4-d-glucopyranosylsulphamethazine by rat everted intestinal sacs. Biochemical Pharmacology. 46(10). 1864–1866. 17 indexed citations
11.
Panjehshahin, Mohammad Reza, Michael S. Yates, & C J Bowmer. (1992). A comparison of drug binding sites on mammalian albumins. Biochemical Pharmacology. 44(5). 873–879. 37 indexed citations
12.
Mackay, Dennis, Mohammad Reza Panjehshahin, & C J Bowmer. (1991). Analysis of the binding of fluorescent ligands to soluble proteins. Biochemical Pharmacology. 41(12). 2011–2018. 6 indexed citations
13.
Evans, Jonathan HC, J T Brocklebank, C J Bowmer, & P C Ng. (1991). Pharmacokinetics of Recombinant Human Erythropoietin in Children with Renal Failure. Nephrology Dialysis Transplantation. 6(10). 709–714. 32 indexed citations
14.
Hartley, R., et al.. (1991). Dissolution and relative bioavailability of two carbamazepine preparations for children with epilepsy. Journal of Pharmacy and Pharmacology. 43(2). 117–119. 28 indexed citations
15.
Knight, Richard J., M G Collis, M S Yates, & C J Bowmer. (1991). Amelioration of cisplatin‐induced acute renal failure with 8‐cyclopentyl‐1,3‐dipropylxanthine. British Journal of Pharmacology. 104(4). 1062–1068. 48 indexed citations
16.
Hartley, R., Mark Lucock, P.C. Ng, et al.. (1990). Factors Influencing Plasma Level/Dose Ratios of Carbamazepine and Its Major Metabolites in Epileptic Children. Therapeutic Drug Monitoring. 12(5). 438–444. 14 indexed citations
17.
Panjehshahin, Mohammad Reza, C J Bowmer, & Michael S. Yates. (1989). A pitfall in the use of double-reciprocal plots to estimate the intrinsic molar fluorescence of ligands bound to albumin. Biochemical Pharmacology. 38(1). 155–159. 19 indexed citations
18.
Bowmer, C J, et al.. (1989). Amelioration of glycerol‐induced acute renal failure in the rat with 8‐cyclopentyl‐1,3‐dipropylxanthine. British Journal of Pharmacology. 98(3). 1066–1074. 48 indexed citations
19.
Silberstein, David, C J Bowmer, & M S Yates. (1988). Dibromosulphophthalein: its pharmacokinetics and binding to hepatic cytosol proteins in rats with acute renal failure. British Journal of Pharmacology. 95(2). 343–352. 2 indexed citations
20.
Yates, M S, et al.. (1987). Effect of 8-phenyltheophylline, enprofylline and hydrochlorothiazide on glycerol-induced acute renal failure in the rat. Journal of Pharmacy and Pharmacology. 39(10). 803–808. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. D. Niedmann Breakdown of academic impact, for papers by M I Sheikh Breakdown of academic impact, for papers by J. D. Tange Breakdown of academic impact, for papers by Ian Kippen Breakdown of academic impact, for papers by Francesca Franco Breakdown of academic impact, for papers by Kwan Leung Breakdown of academic impact, for papers by David Hicks Breakdown of academic impact, for papers by M. Galli-Kienle Breakdown of academic impact, for papers by A. Farah Breakdown of academic impact, for papers by Géraldine M. Ferron
Rankless by CCL
2026